Wakefield Asset Management’s Amgen AMGN Stock Holding History

Wakefield Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$738K	Buy	2,037 +29	+1%	+$9.93K	0.17%	155
2026 Q1	$707K	Sell	2,008 -17	-0.8%	-$6.06K	0.19%	144
2025 Q4	$663K	Buy	2,025 +66	+3%	+$20.9K	0.18%	148
2025 Q3	$553K	Sell	1,959 -15	-0.8%	-$4.35K	0.15%	150
2025 Q2	$551K	Buy	+1,974	New	+$559K	0.15%	155
2024 Q4	–	Sell	-1,228	Closed	-$396K	–	147
2024 Q3	$396K	Buy	1,228 +20	+2%	+$6.54K	0.13%	136
2024 Q2	$377K	Sell	1,208 -390	-24%	-$115K	0.13%	136
2024 Q1	$454K	Sell	1,598 -27	-2%	-$7.9K	0.16%	134
2023 Q4	$468K	Buy	1,625 +533	+49%	+$145K	0.17%	131
2023 Q3	$293K	Sell	1,092 -569	-34%	-$142K	0.13%	141
2023 Q2	$369K	Buy	+1,661	New	+$385K	0.15%	139
2020 Q1	–	Sell	-1,158	Closed	-$279K	–	156
2019 Q4	$279K	Buy	1,158 +60	+5%	+$13.2K	0.12%	140
2019 Q3	$212K	Buy	+1,098	New	+$211K	0.09%	145

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wakefield Asset Management's AMGN Position: Q2 2026 in Review

Wakefield Asset Management increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $9.93K and bringing the position to 2,037 shares worth $738K. The position accounts for 0.17% of the portfolio, ranked #155.

Wakefield Asset Management first reported a position in AMGN in Q3 2019 and has held it in 13 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Wakefield Asset Management held 2,037 shares of Amgen worth $738K as of Q2 2026.
Wakefield Asset Management bought 29 Amgen shares in Q2 2026, an estimated $9.93K.
Amgen made up 0.17% of Wakefield Asset Management's portfolio in Q2 2026, its #155 holding.
Wakefield Asset Management first reported a position in Amgen in Q3 2019 and has held it in 13 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.